Image

ORthosis vs No Orthosis After Surgically Treated Traumatic Thoracolumbar Fractures

ORthosis vs No Orthosis After Surgically Treated Traumatic Thoracolumbar Fractures

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

Rationale: There is no evidence in the current literature regarding the additional value of an orthosis after surgically treated thoracolumbar spine fractures.

Objective: To assess whether an orthosis provides additional pain relief compared to no orthosis after posteriorly fixated thoracolumbar spine fractures. Primary outcome is difference in pain at six weeks post-operatively. Secondary objectives are pain at other moments, pain medication used, pain related disability, quality of life, long-term kyphosis, possible complications, hospital stay, return to work and subjective feeling on benefit or disadvantage from the orthosis.

Study design: Randomized controlled intervention study, non-inferiority trial.

Study population: Dutch speaking patients presented at the VU university medical centre, 18 - 65 years old with a traumatic thoracolumbar spine fracture from Th7 - L4 surgically treated by posterior fixation.

Intervention: One group receives standard care and wears an orthosis after surgery for 12 weeks, to use when in vertical position. The intervention group does not wear an orthosis after surgery.

Main study parameters/endpoints: Main study outcome is the difference in pain noted on the NRS-score at six weeks, ≥ 2 (SD 2,5) change corresponds with a clinically significant change in pain score.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The current guideline for postoperative care regarding dorsal stabilization of spine fractures recommends the use of a post-operative orthosis. While patients generally receive an orthosis for 12 weeks, individual surgeon's believes sometimes gives reason to deviate from this guideline. This is founded by literature that increasingly questions the use of orthoses in the conservative treatment of spine fractures. With the fracture operatively stabilized, the orthosis mainly provides support of gesture and thereby potentially results in pain relief and confidence for patients. On the other hand some patients have a hard time weaning from the orthosis or report discomfort due to the device and prefer not to use it. With subjects being randomized between the use of an orthosis or no orthosis there is no additional risk. This is in part because it is hypothesized that there is no difference in postoperative pain and there might be a lower risk of complications related to the orthosis.

Eligibility

Inclusion Criteria:

  • Age 18 - 65 years
  • Traumatic thoracolumbar spine fracture from thoracic 7 - lumbar 4
  • AO fracture types A-C
  • Undergoing surgical dorsal fixation for fracture

Exclusion Criteria:

  • Inadequate knowledge of Dutch language or to fill in questionnaire
  • Complete or partial spinal cord injury (ASIA A to D)
  • (Additional) anterior surgical stabilization
  • Thoracolumbar fracture of other aetiology than traumatic, e.g. pathologic, infectious
  • Not able to walk before fracturing vertebra
  • Unable to come to the outpatient clinic (e.g. residing outside the Netherlands)
  • Injury Severity Score (ISS) ≥ 16
  • Brain injury with Abbreviated Injury Score (AIS) ≥ 4
  • Solitary Lumbar 5 fracture
  • Inability to wear an orthosis, most probable reasons:
    • BMI > 35
    • Thoraco-abdominal wounds (through trauma or secondary from surgery) on places at which the orthosis contacts the body so aggravation of pain or chances of infection increase significantly.

      12 of 27

    • Pre-existing spine deformities (scoliosis or very severe kyphosis/lordosis) which impair the use of the orthosis or aggravate pain.

Study details
    Spine Fracture
    Orthosis
    Traumatic Fracture
    Posterior Fixation

NCT03097081

Amsterdam UMC, location VUmc

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.